Japanese Yen: Softer footing risk as intervention fades – DBS
DBS Group Research strategist Chang Wei Liang notes that USD/JPY has surged above the mid-162 area as markets probe Japanese authorities’ tolerance for further Japanese Yen (JPY) weakness. He highlights that the absence of fresh, forceful rhetoric from officials is encouraging shorts, while the previous restraint from implicit intervention threats is fading, leaving the JPY potentially on a softer footing despite solid Tankan survey data.
Markets test Japanese Yen tolerance
"USD/JPY has surged above mid-162 levels, with markets testing the Japanese authorities’ tolerance for JPY weakness."
"USD/JPY has accelerated higher after breaking through 162 yesterday, given no new rhetoric to deter shorts by government officials."
"Finance Minister Katayama only said that Japan will take “appropriate action at any time as necessary” yesterday, which has been interpreted by traders as the JPY being somewhat distant from the intervention threshold."
"The previous restraint on JPY weakness from implicit intervention threats is receding, and the JPY could be on a softer footing without more forceful rhetoric."
"Meanwhile, Japan’s Tankan for Q2 released today indicated a solid rise in sentiment across large manufacturing firms (22 vs Q1:17), helped by an exports boom and easing oil prices."
(This article was created with the help of an Artificial Intelligence tool and reviewed by an editor.)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
As global tungsten prices surge, U.S. mining company Almonty Industries (ALM.US) quickly acquires a tungsten mine in Rwanda to ease supply shortages.
U.S. mining company Almonty Industries has signed a tungsten mining agreement in Rwanda, expanding Western supply.
Novo Nordisk (NVO.US) renamed to "Novo" for a fresh start—Can multi-line breakthroughs dispel the shadow over its stock price?
Danish pharmaceutical company Novo Nordisk (NVO.US) has launched a comprehensive rebranding centered around the shorter name "Novo." The company will use "Novo" in daily brand promotion, but its legal name will remain Novo Nordisk A/S.
High interest rates are not the "end" of US stocks? Is profitability the real key?
JPMorgan believes that profit growth is the key factor determining the resilience of U.S. stock valuations. Data since 1950 shows an "inverted U-shaped" relationship between the 10-year U.S. Treasury yield and S&P 500 valuations. Based on current profit levels, yields would need to reach about 5%-6% to significantly compress valuations. As long as profit growth remains above 15%, there is still room for valuations to be re-rated. If the yield curve steepens in a bear market, cyclical sectors such as energy and financials will benefit more; if it flattens, technology stocks will have a relative advantage.
Crypto prices
More
